CYP1A2 and tuberculosis: The metabolic inducers included the anticonvulsant phenytoin, a moderate inducer of CYP1A2; the anti-tuberculosis drug rifampicin, a strong inducer of CYP3A [20]; and the sedative drug dichloralphenazone.